Press release
Malaria and Sickle Cell Disease Treatment Market could be worth US$ 4,457.15 million by 2030,says Premium Market Insights
Malaria and Sickle Cell Disease Treatment Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) The malaria and sickle cell disease treatment market is expected to grow from US$ 4,457.15 million in 2022 to US$ 29,179.60 million by 2030; it is estimated to grow at a CAGR of 26.5% from 2022 to 2030.Get PDF Sample Report + All Related Table and Graphs @: https://www.premiummarketinsights.com/sample/TIP00083402?utm_source=OpenPR&utm_medium=10823
Competitive Landscape: Malaria and Sickle Cell Disease Treatment Market:
The market for malaria and sickle cell disease treatment is growing due to the increasing prevalence of malaria and sickle cell disease and rising government initiatives to raise awareness about malaria and SCD. However, factors such as a counterfeit antimalarial drug and subsequent drug resistance are restraining the market growth. Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial and SCD drug/vaccine pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria and sickle cell disease. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options.
Cipla Ltd
Pfizer Inc
Sun Pharmaceutical Industries Ltd
Sanofi SA
GSK Plc
Novartis AG
Pfizer Inc
Emmaus Life Sciences Inc
AdvaCare Pharma USA LLC
VLP Therapeutics LLC
Lupin Ltd
Bottom of Form
Chapter Details of Malaria and Sickle Cell Disease Treatment Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Malaria and Sickle Cell Disease Treatment Market Landscape
Part 04: Malaria and Sickle Cell Disease Treatment Market Sizing
Part 05: Malaria and Sickle Cell Disease Treatment Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Interested in Purchasing this Report? Click here @ https://www.premiummarketinsights.com/buy/TIP00083402?utm_source=OpenPR&utm_medium=10823
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sushant More
SE-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876
About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Malaria and Sickle Cell Disease Treatment Market could be worth US$ 4,457.15 million by 2030,says Premium Market Insights here
News-ID: 3698513 • Views: …
More Releases from Premium Market Insights
North America Overhead Cranes Market could be worth US$ 1,020.54 million by 2028 …
The North America overhead cranes market is expected to grow from US$ 1,020.54 million in 2022 to US$ 1,558.94 million by 2028. It is estimated to grow at a CAGR of 7.3% from 2022 to 2028. Analysis By Type (Gantry Crane, Bridge Crane, Jib Crane, Monorail Crane, and Others), Installation (Mobile Crane and Fixed Crane), Operation Type (Electric, Hydraulic, and Hybrid), and Verticals (Logistics, Automotive, Marine, and Others)
Get PDF Sample…
Commercial Refrigeration Market to exceed US$ US$ 28.8 billion by 2030, says Pre …
The Commercial Refrigeration Market size is expected to grow from US$ 28.8 billion in 2022 and is expected to reach US$ 49.0 billion by 2030; it is estimated to record a CAGR of 6.9% from 2022 to 2030.Commercial Refrigeration Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Refrigerator, Freezer, Heated Cabinets, Milk Coolers, Chef Bases, Full Size Undercounters,…
Coagulation Market could be worth 6,295.28 million by 2030,,says Premium Market …
The coagulation market is expected to grow from US$ 6,295.28 million in 2022 to US$ 10,853.28 million by 2030; it is anticipated to record a CAGR of 7.0% from 2022 to 2030.Coagulation Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von…
Bread Market to Hit US$ 350.17 billion by2030 ; Premium Market Insights
The bread market was valued at US$ 266.33 billion in 2022 and is projected to reach US$ 350.17 billion by 2030; it is expected to register a CAGR of 3.4% from 2022 to 2030.Bread Market Forecast to 2030 - COVID-19 Impact and Global Analysis By Type (Loaves, Sandwich Bread, Baguettes, Burger Buns, and Others); Category (Organic and Conventional); Distribution Channel (Supermarkets and Hypermarkets, Specialty Stores, Online Retail, and Others)
Get PDF…
More Releases for Malaria
Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview
Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous…
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database.
Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional…
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Malaria Diagnostics Market : Future Growth Potential Of The Malaria Diagnostic & …
Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in…
